Compound information
- Natural Products
- ZC1064545
- Molecular Formula
- C12H15NO
- Molecular Weight
- 189.1153641 g/mol
- Structure
-
- IUPAC Name
- N-(4-isopropylphenyl)prop-2-enamide
- InChI
- InChI=1S/C12H15NO/c1-4-12(14)13-11-7-5-10(6-8-11)9(2)3/h4-9H,1H2,2-3H3,(H,13,14)
- InChI Key
- UWFOOYAOKYLMKZ-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(C(C)C)cc1
- Source
- ZINC000036334224
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 14 | Ring Count | 1 |
Heteroatom Count | 2 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 1 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 29.1 Å2 | LogP | 3.316 |
LogS | -3.761 | LogD | 2.96 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.062 | Pgp substrate | 0.917 |
HIA | 0.964 | F20 % | 0.989 |
F30 % | 0.717 | Caco-2 | -4.49 |
MDCK | -4.582 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.898 | PPB | 90.894 |
VD | 1.071 | Fu | 1.699 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.985 | CYP1A2 substrate | 0.632 |
CYP2A6 substrate | 0.687 | CYP2B6 substrate | 0.461 |
CYP2C19 inhibitor | 0.847 | CYP2C19 substrate | 0.744 |
CYP2C8 substrate | 0.7 | CYP2C9 inhibitor | 0.227 |
CYP2C9 substrate | 0.129 | CYP2D6 inhibitor | 0.028 |
CYP2D6 substrate | 0.486 | CYP2E1 substrate | 0.769 |
CYP3A4 inhibitor | 0.019 | CYP3A4 substrate | 0.864 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.457 | CL | 9.636 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.024 | Hepatotoxicity | 0.867 |
Mutagenicity | 0.009 | Rat Oral Acute Toxicity | 0.026 |
FDAMDD | 0.246 | Skin Sensitization | 0.997 |
Carcinogenicity | 0.202 | Eye Corrosion | 0.248 |
Eye Irritation | 0.946 | Respiratory Toxicity | 0.029 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.149 | IGC50 | 3.804 |
LC50FM | 4.807 | LC50DM | 4.815 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.091 | NR-AR-LBD | 0.23 |
NR-AhR | 0.447 | NR-Aromatase | 0.065 |
NR-ER | 0.415 | NR-ER-LBD | 0.449 |
NR-PPAR-gamma | 0.792 | SR-ARE | 0.628 |
SR-ATAD5 | 0.566 | SR-HSE | 0.182 |
SR-MMP | 0.467 | SR-p53 | 0.647 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.